Search

Your search keyword '"Vela, C"' showing total 415 results
Start Over Author "Vela, C"
415 results on '"Vela, C"'

1. Rethinking the PPP strategy concept : towards consistency in discourse and management

Author

Pardo, Vela C., Hunt, Michael, Clark, M., and Mcauley, John

Subjects
658
Abstract

This research explores the phenomenon of inter-organisational collaboration between public and private organisations in public-private partnerships (PPPs). The state's need for cost savings, capital, and greater efficiency has been accentuated by the recent global economic instability and, forecasts suggest that governments, particularly in Europe, will increasingly enter into partnerships with the private sector in the future. In contracting out public services investment through the collaboration with private sector the British experience is considered an international reference, the National Health Service (NHS) being a relevant example and also one of the most controversial contexts for the intervention of the private sector. However, few previous studies have analysed collaborative provision of ancillary services in this context. To conduct such a study, the concept of "partnership" required further clarification in both theoretical and management terms. To this end, the research focused on the leading drivers and governing influences and players, and on the working climate generated, including the socio relational dimension and involved dynamics. The study was conducted by means of a multi case study methodology based on semi-structured interviews, focus groups and additional documentary information. Participants' values and expectations in terms of working in partnership were examined as well as implementation and governance practices of the concept of PPP, in order to identify the connection between theory and practice. Finally, a model was developed for enhancing partnership between public and private organisations, grounded in the principles of relational management theories and in accordance with the particularities of this research context. The main issue identified is that the drivers behind the formation of partnering agreements are not in tune with the concept of partnership. The explored PPPs cases manifested a highly transactional nature, representing contractual exchange relationships characterised by formalised methods of task control and assessment rather than by trust based collaboration. There was a lack of a supportive governance structure in terms of the principles of partnership that the state had avowedly adopted. This research maintains that managing the relational dimension serves as a catalyst for the success of PPPs and that these partnerships are not embedded within organisations; rather, their development depends on having the right people in place. The PPP site manager's aptitude and attitude are key factors. This study highlights the need for consistency in the practice of partnership in terms of providing a balance between the level of formalisation and attention to the socio-relational dimension. PPPs are not benefiting in full from collaboration due to the neglect of the public/private relationship as a source of added value. This research urges the government to turn the concept of partnership into a reality instead of fostering anti-collaborative relationships. A model is suggested providing guidance on the strategic management of PPPs beyond limiting partnership to mere fulfilment of outcomes.

Published
2013

2. Persistent effects of pre-Columbian plant domestication on Amazonian forest composition

Author

Levis, C., Costa, F. R. C., Bongers, F., Peña-Claros, M., Clement, C. R., Junqueira, A. B., Neves, E. G., Tamanaha, E. K., Figueiredo, F. O. G., Salomão, R. P., Castilho, C. V., Magnusson, W. E., Phillips, O. L., Guevara, J. E., Sabatier, D., Molino, J.-F., López, D. Cárdenas, Mendoza, A. M., Pitman, N. C. A., Duque, A., Vargas, P. Núñez, Zartman, C. E., Vasquez, R., Andrade, A., Camargo, J. L., Feldpausch, T. R., Laurance, S. G. W., Laurance, W. F., Killeen, T. J., Nascimento, H. E. Mendonça, Montero, J. C., Mostacedo, B., Amaral, I. L., Vieira, I. C. Guimarães, Brienen, R., Castellanos, H., Terborgh, J., de Jesus Veiga Carim, M., da Silva Guimarães, J. R., de Souza Coelho, L., de Almeida Matos, F. D., Wittmann, F., Mogollón, H. F., Damasco, G., Dávila, N., García-Villacorta, R., Coronado, E. N. H., Emilio, T., de Andrade Lima Filho, D., Schietti, J., Souza, P., Targhetta, N., Comiskey, J. A., Marimon, B. S., Marimon, B.-H., Neill, D., Alonso, A., Arroyo, L., Carvalho, F. A., de Souza, F. C., Dallmeier, F., Pansonato, M. P., Duivenvoorden, J. F., Fine, P. V. A., Stevenson, P. R., Araujo-Murakami, A., Aymard C., G. A., Baraloto, C., do Amaral, D. D., Engel, J., Henkel, T. W., Maas, P., Petronelli, P., Revilla, J. D. Cardenas, Stropp, J., Daly, D., Gribel, R., Paredes, M. Ríos, Silveira, M., Thomas-Caesar, R., Baker, T. R., da Silva, N. F., Ferreira, L. V., Peres, C. A., Silman, M. R., Cerón, C., Valverde, F. C., Di Fiore, A., Jimenez, E. M., Mora, M. C. Peñuela, Toledo, M., Barbosa, E. M., de Matos Bonates, L. C., Arboleda, N. C., de Sousa Farias, E., Fuentes, A., Guillaumet, J.-L., Jørgensen, P. Møller, Malhi, Y., de Andrade Miranda, I. P., Phillips, J. F., Prieto, A., Rudas, A., Ruschel, A. R., Silva, N., von Hildebrand, P., Vos, V. A., Zent, E. L., Zent, S., Cintra, B. B. L., Nascimento, M. T., Oliveira, A. A., Ramirez-Angulo, H., Ramos, J. F., Rivas, G., Schöngart, J., Sierra, R., Tirado, M., van der Heijden, G., Torre, E. V., Wang, O., Young, K. R., Baider, C., Cano, A., Farfan-Rios, W., Ferreira, C., Hoffman, B., Mendoza, C., Mesones, I., Torres-Lezama, A., Medina, M. N. U., van Andel, T. R., Villarroel, D., Zagt, R., Alexiades, M. N., Balslev, H., Garcia-Cabrera, K., Gonzales, T., Hernandez, L., Huamantupa-Chuquimaco, I., Manzatto, A. G., Milliken, W., Cuenca, W. P., Pansini, S., Pauletto, D., Arevalo, F. R., Reis, N. F. Costa, Sampaio, A. F., Giraldo, L. E. Urrego, Sandoval, E. H. Valderrama, Gamarra, L. Valenzuela, Vela, C. I. A., and ter Steege, H.

Published
2017

11. Surveillance of Immunological Status after Vaccination by two Serological Assays based on SARS-CoV-2 Spike Protein

Author

Fresco-Taboada, A., primary, Garcia-Duran, M., additional, Aira, C., additional, López, L., additional, Sastre, P., additional, Van der Hoek, L., additional, Van Gils, M., additional, Brouwer, P.J.M., additional, Sanders, R.W., additional, Holzer, B., additional, Zimpernik, I., additional, López-Collazo, E., additional, Muñoz, P., additional, Rueda, P., additional, and Vela, C., additional

Published
2022
Full Text
View/download PDF

13. Pregnancy control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn

Author

Delgado P, Robles Á, Martínez López JA, Sáez-Comet L, Rodríguez Almaraz E, Martínez-Sánchez N, Ugarte A, VELA C, Marco B, Espinosa G, Galindo M, Casellas M, Ruiz-Irastorza G, Martínez-Taboada V, and Bartha JL

Subjects
Embarazo, Lactancia, Puerperium, Síndrome antifosfolípido, Anticoncepción, Contraception, Systemic lupus erythematosus, immune system diseases, Pregnancy, Antiphospholipid syndrome, Lupus eritematoso sistémico, Lactation, skin and connective tissue diseases, Puerperio
Abstract

Objective: In order to agree on the fundamental aspects related to the management of pregnancy in patients with systemic lupus erythematosus and antiphospholipid syndrome, the Spanish Societies of Gynaecology and Obstetrics, Internal Medicine and Rheumatology have set up a working group for the preparation of three consensus documents. Methods: Each of the Scientific Societies involved proposed five representatives based on their experience in the field of pregnancy control in patients with autoimmune diseases. The recommendations were developed following the Delphi methodology. Results: This third document contains the recommendations regarding the management of delivery, puerperium and lactation, including medication use during these periods and the care of the newborn. In addition, a section on contraception is included. Conclusions: These multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with systemic lupus erythematosus/antiphospholipid syndrome during pregnancy. (c) 2019 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.

Published
2021

14. Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up

Author

Rodríguez Almaraz E, Sáez-Comet L, Casellas M, Delgado P, Ugarte A, VELA C, Martínez Sánchez N, Galindo-Izquierdo M, Espinosa G, Marco B, Martínez López JA, Robles A, Martínez-Taboada V, Bartha JL, and Ruiz-Irastorza G

Subjects
Embarazo, Lactancia, Puerperium, Síndrome antifosfolípido, Anticoncepción, Antiphospholipid syndrome, Contraception, Embarazo, Lactancia, Lactation, Lupus eritematoso sistémico, Pregnancy, Puerperio, Puerperium, Systemic lupus erythematosus, Síndrome antifosfolípido, Anticoncepción, Contraception, Systemic lupus erythematosus, immune system diseases, Pregnancy, Antiphospholipid syndrome, Lupus eritematoso sistémico, Lactation, skin and connective tissue diseases, Puerperio
Abstract

OBJECTIVE: In order to agree on the fundamental aspects related to the management of pregnancy in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), the Spanish Societies of Gynaecology and Obstetrics, Internal Medicine and Rheumatology set up a working group for the preparation of three consensus documents. METHODS: Each of the Scientific Societies involved proposed five representatives based on their experience in the field of pregnancy control in patients with autoimmune diseases. The recommendations were developed following the Delphi methodology. RESULTS: This second document contains the recommendations regarding the management of pregnancy in women with SLE and APS, including complications such as lupus activity, congenital heart block, thrombotic and obstetric manifestations of APS and placental vascular disease. CONCLUSIONS: These multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with SLE/APS during pregnancy.

Published
2021

15. Combined Control and Navigation Approach to the Robotic Capture of Space Vehicles

Author

Pavanello, Z., Branz, F., Francesconi, A., Cenedese, A., Antonello, R., Basana, F., Iob, P., Vertuani, D., Massari, M., Colombo, C., Lovera, M., Invernizzi, D., Ghignoni, P., Ticozzi, L., Giacomo Borelli, Opromolla, R., Grassi, M., Fasano, G., Nocerino, A., Lombardi, C., Vela, C., Garciad, I. H., Simplicio, P., Pavanello, Zeno, Branz, Francesco, Francesconi, Alessandro, Cenedese, Angelo, Antonello, Riccardo, Basana, Federico, Iob, Pietro, Vertuani, Davide, Massari, Mauro, Colombo, Camilla, Lovera, Marco, Invernizzi, Davide, Ghignoni, Pietro, Ticozzi, Lorenzo, Borelli, Giacomo, Opromolla, Roberto, Grassi, Michele, Fasano, Giancarmine, Nocerino, Alessia, Lombardi, Carlo, Vela, Claudio, Huertas Garcia, Irene, and Simplicio, Pedro

Subjects
Close Proximity Operations, Space manipulator combined control, Relative navigation algorithm, GNC
Abstract

The potentialities of In-Orbit Servicing (IOS) to extend the operational life of satellites and the need to implement Active Debris Removal (ADR) to effectively tackle the space debris problem are well known among the space community. Research on technical solutions to enable this class of missions is thriving, also pushed by the development of new generation sensors and control systems. Among private companies, space agencies and universities, the European Space Agency (ESA) has been developing technologies in this field for decades. Several solutions have been proposed over the years to safely capture orbital objects, the majority relying on robotic systems. A promising option is the employment of an autonomous spacecraft (chaser) equipped with a highly dexterous robotic arm able to perform the berthing with a resident space object. This operation poses complex technical challenges both during the approach phase and after contact. In this respect, the design of an effective, reliable, and robust Guidance, Navigation and Control (GNC) system, for which several algorithmic architectures and hardware configurations are possible, plays a key role to ensure safe mission execution. This work presents the outcomes of a research activity performed by a consortium of universities under contract with ESA with the goal to develop the navigation and control subsystems of a GNC system for controlling a chaser equipped with a redundant manipulator. Both the final approach until capture and the target stabilization phase after capture are considered in the study. The proposed solution aims at the implementation of a combined control strategy. Robust control methods are adopted to design control laws for the uncertain, nonlinear dynamics of the chaser and of the complete chaser–target stack after capture. Visual–based solutions, i.e., relying on active/passive electro– optical sensors, are selected for relative navigation. A complete sensor suite for relative and absolute navigation is part of the GNC system, including transducers for robot joint measurements. To properly validate the proposed solutions, a complete numerical simulator has been developed. This software tool allows to thoroughly assess the system performance, accounting for all the relevant external disturbances and error sources. A realistic synthetic image generator is also used for relative navigation performance assessment. This paper presents the design solutions and the results of preliminary numerical testing, considering three mission scenarios to prove the flexibility of the solution and its applicability to a wide range of operational cases.

Published
2021

17. Le filologie della letteratura italiana. Modelli, esperienze, prospettive. Atti del Convegno internazionale, Roma, 28-30 novembre 2019

Author

S. Brambilla (ORCID:0000-0003-0193-5919), Berisso, M., Berté, M., Brambilla, Simona, Calenda, C., Corfiati, C., Gionta, D., Vela, C., S. Brambilla (ORCID:0000-0003-0193-5919), Berisso, M., Berté, M., Brambilla, Simona, Calenda, C., Corfiati, C., Gionta, D., and Vela, C.

Abstract

Il volume raccoglie contributi relativi alle varie declinazioni della Filologia della letteratura italiana.

Published
2021

19. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

Author

Cruz, B, Alonso, F, Alen, J, Pego-Reigosa, J, Lopez-Longo, F, Galindo-Izquierdo, M, Olive, A, Tomero, E, Horcada, L, Uriarte, E, Erausquin, C, Sanchez-Atrio, A, Montilla, C, Soler, G, Fernandez-Nebro, A, Blanco, R, Rodriguez-Gomez, M, Vela C, Freire, M, Diez-Alvarez, E, Boteanu, A, Narvaez, J, Taboada, V, Ruiz-Lucea, E, Andreu, J, Fernandez-Berrizbeitia, O, Hernandez-Beriain, J, Gantes, M, Perez-Venegas, J, Ibanez-Barcelo, M, Pecondon-Espanol, A, Marras, C, Bonilla, G, Castellvi, I, Moreno, M, Raya, E, Vila, V, Vazquez, T, Ruan, J, Munoz, S, Rua-Figueroa, I, and RELESSER Spanish Soc Rheumatology

Subjects
Male, severity index, medicine.medical_specialty, Latin Americans, Hispanics, Ethnic group, Severity of Illness Index, White People, 03 medical and health sciences, 0302 clinical medicine, Systemic lupus erythematosus, Rheumatology, immune system diseases, medicine, Humans, Lupus Erythematosus, Systemic, Registries, 030212 general & internal medicine, Retrospective Studies, 030203 arthritis & rheumatology, Autoimmune disease, Lupus erythematosus, business.industry, medicine.disease, Dermatology, Latin America, Spain, Disease Progression, ethnicity, Female, business
Abstract

Background Systemic lupus erythematosus (SLE) is regarded as a prototype autoimmune disease because it can serve as a means for studying differences between ethnic minorities and sex. Traditionally, all Hispanics have been bracketed within the same ethnic group, but there are differences between Hispanics from Spain and those from Latin America, not to mention other Spanish-speaking populations. Objectives This study aimed to determine the demographic and clinical characteristics, severity, activity, damage, mortality and co-morbidity of SLE in Hispanics belonging to the two ethnic groups resident in Spain, and to identify any differences. Methods This was an observational, multi-centre, retrospective study. The demographic and clinical variables of patients with SLE from 45 rheumatology units were collected. The study was conducted in accordance with Good Clinical Practice guidelines. Hispanic patients from the registry were divided into two groups: Spaniards or European Caucasians (EC) and Latin American mestizos (LAM). Comparative univariate and multivariate statistical analyses were carried out. Results A total of 3490 SLE patients were included, 90% of whom were female; 3305 (92%) EC and 185 (5%) LAM. LAM patients experienced their first lupus symptoms four years earlier than EC patients and were diagnosed and included in the registry younger, and their SLE was of a shorter duration. The time in months from the first SLE symptoms to diagnosis was longer in EC patients, as were the follow-up periods. LAM patients exhibited higher prevalence rates of myositis, haemolytic anaemia and nephritis, but there were no differences in histological type or serositis. Anti-Sm, anti-Ro and anti-RNP antibodies were more frequently found in LAM patients. LAM patients also had higher levels of disease activity, severity and hospital admissions. However, there were no differences in damage index, mortality or co-morbidity index. In the multivariate analysis, after adjusting for confounders, in several models the odds ratio (95% confidence interval) for a Katz severity index >3 in LAM patients was 1.45 (1.038–2.026; p = 0.02). This difference did not extend to activity levels (i.e. SLEDAI >3; 0.98 (0.30–1.66)). Conclusion SLE in Hispanic EC patients showed clinical differences compared to Hispanic LAM patients. The latter more frequently suffered nephritis and higher severity indices. This study shows that where lupus is concerned, not all Hispanics are equal.

Published
2020

23. THU0297 SERIOUS INFECTIONS IN 134 PATIENTS WITH GIANT CELL ARTERITIS WITH TOCILIZUMAB IN CLINICAL PRACTICE. FREQUENCY, TYPE AND CLINICAL ASSOCIATIONS

Author

Calderón-Goercke, M., primary, Prieto-Peña, D., additional, Castañeda, S., additional, Moriano, C., additional, Becerra-Fernández, E., additional, Revenga, M., additional, Alvarez-Rivas, N., additional, Galisteo, C., additional, Prior-Español, Á., additional, Galindez, E., additional, Hidalgo, C., additional, Manrique Arija, S., additional, De Miguel, E., additional, Salgado-Pérez, E., additional, Aldasoro, V., additional, Villa-Blanco, I., additional, Romero-Yuste, S., additional, Narváez, J., additional, Gomez-Arango, C., additional, Perez-Pampín, E., additional, Melero, R., additional, Sivera, F., additional, Fernández-Díaz, C., additional, Olive, A., additional, Álvarez del Buergo, M., additional, Marena Rojas, L., additional, Fernández-López, C., additional, Navarro, F., additional, Raya, E., additional, Arca, B., additional, Solans-Laqué, R., additional, Conesa, A., additional, Vázquez, C., additional, Román-Ivorra, J. A., additional, Lluch, P., additional, Vela-Casasempere, P., additional, Torres-Martín, C., additional, Nieto, J. C., additional, Ordas-Calvo, C., additional, Luna-Gomez, C., additional, Toyos Sáenz de Miera, F. J., additional, Fernández-Llanio, N., additional, García, A., additional, González-Vela, C., additional, García-Fernández, J., additional, Vicente-Gómez, P., additional, García-Manzanares, Á., additional, Ortego, N., additional, Ortiz-Sanjuán, F., additional, Corteguera, M., additional, Hernández, J. L., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2020
Full Text
View/download PDF

25. Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports

Author

Ivorra, J, Fernandez-Llanio-Comella, N, San-Martin-Alvarez, A, Vela C, Sauri-Ferrer, I, Gonzalez-de-Julian, S, and Vivas-Consuelo, D

Subjects
Patient-reported outcomes, Systemic lupus erythematosus, Patient costs, Health-related quality of life
Abstract

INTRODUCTION AND OBJECTIVES: Systemic lupus erythematosus (SLE) is a disease that significantly affects the quality of life and welfare of patients. SLE patients can be classified into multimorbidity levels using Clinical Risk Groups (CRGs) to help to incorporate predictive models of health needs. The goal of this study was to correlate CRGs with health-related quality of life (HR-QoL) and costs in SLE patients. METHODS: A questionnaire was administered to SLE patients in four hospital centers of the Valencian Community (Spain) between October 2015 and March 2016. The factors studied included HR-QoL (EQ-5D-5L and VAS), disease activity (SLAI/SELENA), damage (SLICC/ACR), and severity (IGK). RESULTS: The patients (N = 190, 92.06% female, age (mean ± SD) 47.23 ± 13.43 years) were sorted according to health status in nine CRGs. We found that most SLE patients (> 70%) were in CRGs 5 and 6. The main HR-QoL issues in these patients were related to mobility, ability to perform usual activities, and pain/discomfort. The scores (mean ± SD) for EQ-5D-5L and VAS were 0.74 ± 0.25 and 65.67 ± 23.52, respectively. We found that the age of the patients negatively affected their HR-QoL (r = - 0.266). SLE direct costs per patient increased with each CRG group, representing 71.92% of the total costs, while indirect costs were highly variable. The average cost per patient with SLE amounted to €8432.85 (year 2014). CONCLUSIONS: Patients' quality of life is related with age, disease activity, damage, and severity. Age was the parameter which most affects HR-QoL. Most costs of SLE are concentrated in two CRGs in which the HR-QoL deteriorates sharply.

Published
2019

26. HORMONE DEPENDENCE AND CANCER IN SYSTEMIC LUPUS ERYTHEMATOSUS

Author

Cobo-Ibanez, T, Urruticoechea-Arana, A, Rua-Figueroa, I, Martin-Martinez, M, Ovalles, J, Galindo-Izquierdo, M, Calvo-Alen, J, Olive, A, Fernandez-Nebro, A, Menor-Almagro, R, Muriel, E, Horcada, L, Isacelaya, E, Taboada, V, Andreu, J, Boteanu, A, Narvaez, J, Bohorquez, C, Montilla-Morales, C, Soler, G, Hernandez-Cruz, B, Vela C, Perez, E, Gonzalez, M, Beriain, J, Alvarez, E, Exposito, L, Fernandez-Berrizbeitia, O, Marenco, J, Pego-Reigosa, J, and RELESSER Study Grp

Published
2019

29. Compositional response of Amazon forests to climate change

Author

Esquivel-Muelbert, A., Baker, T.R., Dexter, K.G., Lewis, S.L., Brienen, R.J.W., Feldpausch, T.R., Lloyd, J., Monteagudo-Mendoza, A., Arroyo, L., Álvarez-Dávila, E., Higuchi, N., Marimon, B.S., Marimon-Junior, B.H., Silveira, M., Vilanova, E., Gloor, E., Malhi, Y., Chave, J., Barlow, J., Bonal, D., Davila Cardozo, N., Erwin, T., Fauset, S., Hérault, B., Laurance, S., Poorter, L., Qie, L., Stahl, C., Sullivan, M.J.P., ter Steege, H., Vos, V.A., Zuidema, P.A., Almeida, E., Almeida de Oliveira, E., Andrade, A., Vieira, S.A., Aragão, L., Araujo-Murakami, A., Arets, E., Aymard C, G.A., Baraloto, C., Camargo, P.B., Barroso, J.G., Bongers, F., Boot, R., Camargo, J.L., Castro, W., Chama Moscoso, V., Comiskey, J., Cornejo Valverde, F., Lola da Costa, A.C., del Aguila Pasquel, J., Di Fiore, A., Fernanda Duque, L., Elias, F., Engel, J., Flores Llampazo, G., Galbraith, D., Herrera Fernández, R., Honorio Coronado, E., Hubau, W., Jimenez-Rojas, E., Lima, A.J.N., Umetsu, R.K., Laurance, W., Lopez-Gonzalez, G., Lovejoy, T., Aurelio Melo Cruz, O., Morandi, P.S., Neill, D., Núñez Vargas, P., Pallqui Camacho, N.C., Parada Gutierrez, A., Pardo, G., Peacock, J., Peña-Claros, M., Peñuela-Mora, M.C., Petronelli, P., Pickavance, G.C., Pitman, N., Prieto, A., Quesada, C., Ramírez-Angulo, H., Réjou-Méchain, M., Restrepo Correa, Z., Roopsind, A., Rudas, A., Salomão, R., Silva, N., Silva Espejo, J., Singh, J., Stropp, J., Terborgh, J., Thomas, R., Toledo, M., Torres-Lezama, A., Valenzuela Gamarra, L., van de Meer, P.J., van der Heijden, G., van der Hout, P., Vasquez Martinez, R., Vela, C., Vieira, I.C.G., Phillips, O.L., Esquivel-Muelbert, A., Baker, T.R., Dexter, K.G., Lewis, S.L., Brienen, R.J.W., Feldpausch, T.R., Lloyd, J., Monteagudo-Mendoza, A., Arroyo, L., Álvarez-Dávila, E., Higuchi, N., Marimon, B.S., Marimon-Junior, B.H., Silveira, M., Vilanova, E., Gloor, E., Malhi, Y., Chave, J., Barlow, J., Bonal, D., Davila Cardozo, N., Erwin, T., Fauset, S., Hérault, B., Laurance, S., Poorter, L., Qie, L., Stahl, C., Sullivan, M.J.P., ter Steege, H., Vos, V.A., Zuidema, P.A., Almeida, E., Almeida de Oliveira, E., Andrade, A., Vieira, S.A., Aragão, L., Araujo-Murakami, A., Arets, E., Aymard C, G.A., Baraloto, C., Camargo, P.B., Barroso, J.G., Bongers, F., Boot, R., Camargo, J.L., Castro, W., Chama Moscoso, V., Comiskey, J., Cornejo Valverde, F., Lola da Costa, A.C., del Aguila Pasquel, J., Di Fiore, A., Fernanda Duque, L., Elias, F., Engel, J., Flores Llampazo, G., Galbraith, D., Herrera Fernández, R., Honorio Coronado, E., Hubau, W., Jimenez-Rojas, E., Lima, A.J.N., Umetsu, R.K., Laurance, W., Lopez-Gonzalez, G., Lovejoy, T., Aurelio Melo Cruz, O., Morandi, P.S., Neill, D., Núñez Vargas, P., Pallqui Camacho, N.C., Parada Gutierrez, A., Pardo, G., Peacock, J., Peña-Claros, M., Peñuela-Mora, M.C., Petronelli, P., Pickavance, G.C., Pitman, N., Prieto, A., Quesada, C., Ramírez-Angulo, H., Réjou-Méchain, M., Restrepo Correa, Z., Roopsind, A., Rudas, A., Salomão, R., Silva, N., Silva Espejo, J., Singh, J., Stropp, J., Terborgh, J., Thomas, R., Toledo, M., Torres-Lezama, A., Valenzuela Gamarra, L., van de Meer, P.J., van der Heijden, G., van der Hout, P., Vasquez Martinez, R., Vela, C., Vieira, I.C.G., and Phillips, O.L.

Abstract

Most of the planet's diversity is concentrated in the tropics, which includes many regions undergoing rapid climate change. Yet, while climate-induced biodiversity changes are widely documented elsewhere, few studies have addressed this issue for lowland tropical ecosystems. Here we investigate whether the floristic and functional composition of intact lowland Amazonian forests have been changing by evaluating records from 106 long-term inventory plots spanning 30 years. We analyse three traits that have been hypothesized to respond to different environmental drivers (increase in moisture stress and atmospheric CO 2 concentrations): maximum tree size, biogeographic water-deficit affiliation and wood density. Tree communities have become increasingly dominated by large-statured taxa, but to date there has been no detectable change in mean wood density or water deficit affiliation at the community level, despite most forest plots having experienced an intensification of the dry season. However, among newly recruited trees, dry-affiliated genera have become more abundant, while the mortality of wet-affiliated genera has increased in those plots where the dry season has intensified most. Thus, a slow shift to a more dry-affiliated Amazonia is underway, with changes in compositional dynamics (recruits and mortality) consistent with climate-change drivers, but yet to significantly impact whole-community composition. The Amazon observational record suggests that the increase in atmospheric CO 2 is driving a shift within tree communities to large-statured species and that climate changes to date will impact forest composition, but long generation times of tropical trees mean that biodiversity change is lagging behind climate change.

Published
2019

32. Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease

Author

Villain, Cédric, Metzger, Marie, Combe, Christian, Fouque, Denis, Frimat, Luc, Jacquelinet, Christian, Laville, Maurice, Briançon, Serge, Klein, Julie, Schanstra, Joost, Robinson, Bruce, Mansencal, Nicolas, Stengel, Bénédicte, Massy, Ziad, Hannedouche, T, Moulin, B., Klein, A, Bourdenx, J, Keller, A, Delclaux, C, Vendrely, B., Deroure, B, Lacraz, A, Lobbedez, T., Landru, I, Lang, P., Belenfant, X., Thervet, E., Urena, P, Delahousse, M, Vela, C, Essig, M, Sekhri, H, Smati, M, Jamali, M, Hacq, B, Panescu, V, Bellou, M, Kamar, Nassim, Noël, C., Glowacki, F., Maisonneuve, N, Azar, R., Hoffmann, M, Hourmant, M., Testa, A, Besnier, D., Choukroun, Gabriel, Lambrey, G, Burtey, Stéphane, Lebrun, G, Magnant, E, Juillard, L., Chazot, C, Zaoui, P, Kuentz, F, Hôpital Ambroise Paré [AP-HP], Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Néphrologie-Transplantation-Dialyse, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Bioingénierie tissulaire (BIOTIS), Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Agence de la biomédecine [Saint-Denis la Plaine], Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Fédérale Toulouse Midi-Pyrénées, Arbor Research Collaborative for Health, Service Néphrologie/Dialyse [AP-HP Ambroise-Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP], CKD REIN, and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, 030232 urology & nephrology, Renal function, 030204 cardiovascular system & hematology, Coronary artery disease, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Prevalence, medicine, Humans, Prospective Studies, cardiovascular diseases, Renal Insufficiency, Chronic, Aged, Aged, 80 and over, Transplantation, business.industry, valvular heart disease, Age Factors, Odds ratio, Middle Aged, medicine.disease, Plaque, Atherosclerotic, 3. Good health, Cardiovascular Diseases, Nephrology, Heart failure, Cohort, Albuminuria, Cardiology, Female, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, France, medicine.symptom, business, Glomerular Filtration Rate, Kidney disease
Abstract

Background Although chronic kidney disease (CKD) and age are major risk factors for cardiovascular disease (CVD), little is known about the relative proportions of atheromatous and non-atheromatous CVD by age in CKD patients. Methods We used baseline data from the French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort of 3033 patients (65% men) with CKD Stages 3–4 to study crude and adjusted associations between age, the estimated glomerular filtration rate (eGFR), atheromatous CVD (coronary artery disease, peripheral artery disease and stroke) and non-atheromatous CVD (heart failure, cardiac arrhythmia and valvular heart disease). Results Mean age was 66.8 and mean Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFR was 32.9 mL/min/1.73 m2. In the Conclusions In this large cohort of CKD patients, both atheromatous and non-atheromatous CVD were highly prevalent and more frequent in older patients. In a given age group, the prevalence of atheromatous and non-atheromatous CVD was similar (except for a greater prevalence of non-atheromatous CVD after 85).

Published
2018
Full Text
View/download PDF

33. Variation in antiosteoporotic drug prescribing and spending across Spain. A population-based ecological cross-sectional study

Author

Sanfélix-Gimeno, G., Librero-López, J., Modroño-Riaño, G., Peiró, S., Rodríguez-Bernal, C.L., Celaya, M.C., Aza, M., Pradas, F., Bernal-Delgado, E., Cabañas, A.L., Maizal, M.E., Calvo, C.B., López, T.M., Alemán, C.S., Vela, C., Pacheco, L.P., Lirola, M.Á.G., Ruiz, F.R., Riaño, G.M., Martín, M.V.M., Castaño, E., Pérez, M.D.F., Bilbao, J.L.A., Berenguer, J.A.D., Francés, A.E., Cabeza, A., Trujillo, C.D., Martín, N., Ceruelo, J., Magem, D., Robles, G.A.S., Sainz, L., Fernández, F., Montes, G., Martos, E.C., Mataix, Á., Delicado, R.H., Sanz, M.A., Sitges, L.M., Andía, A.A., Parra, F.J.G., GorrichoMendivil, J., López, J.E., Barandiarán, F.A., Picado, A.L., Artaza, E.R.V., Iribar, J., Cuñado, M.A., Librero, S.P.J., and García-Gil, M.

Abstract

Introduction: Evidence has shown that utilization of antiosteoporotic medications does not correspond with risk, and studies on other therapies have shown that adequacy of pharmaceutical prescribing might vary between regions. Nevertheless, very few studies have addressed the variability in osteoporotic drug consumption. We aimed to describe variations in pharmaceutical utilization and spending on osteoporotic drugs between Health Areas (HA) in Spain. Methods: Population-based cross-sectional ecological study of expenditure and utilization of the five therapeutic groups marketed for osteoporosis treatment in Spain in 2009. Small area variation analysis (SAVA) methods were used. The units of analysis were the 168 HA of 13 Spanish regions, including 7.2 million women aged 50 years and older. The main outcomes were the defined daily dose (DDD) per 1000 inhabitants and day (DDD/1000/Day) dispensed according to the pharmaceutical claims reimbursed, and the expenditure on antiosteoporotics at retail price per woman =50 years old and per year. Results: The average osteoporosis drug consumption was 116.8 DDD/1000W/Day, ranging from 78.5 to 158.7 DDD/1000W/Day between the HAs in the 5th and 95th percentiles. Seventy-five percent of the antiosteoporotics consumed was bisphosphonates, followed by raloxifene, strontium ranelate, calcitonins, and parathyroid hormones including teriparatide. Regarding variability by therapeutic groups, biphosphonates showed the lowest variation, while calcitonins and parathyroid hormones showed the highest variation. The annual expenditure on antiosteoporotics was €426.5 million, translating into an expenditure of €59.2 for each woman =50 years old and varying between €38.1 and €83.3 between HAs in the 5th and 95th percentiles. Biphosphonates, despite accounting for 79% of utilization, only represented 63% of total expenditure, while parathyroid hormones with only 1.6% of utilization accounted for 15% of the pharmaceutical spending. Conclusion: This study highlights a marked geographical variation in the prescription of antiosteoporotics, being more pronounced in the case of costly drugs such as parathyroid hormones. The differences in rates of prescribing explained almost all of the variance in drug spending, suggesting that the difference in prescription volume between territories, and not the price of the drugs, is the main source of variation in this setting. Data on geographical variation of prescription can help guide policy proposals for targeting areas with inadequate antiosteoporotic drug use.

Published
2018

34. UTILITY OF APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHCET'S DISEASE

Author

Atienza-Mateo B, Loricera J, Garcia-Armario M, Castellvi I, Sivera F, Grana J, Calvo-Alen J, de la Morena I, Ortiz-Sanjuan F, Roman-Ivorra J, Perez-Gomez A, Heredia S, Diez C, Alegre J, Moriano C, Diez E, Perez T, Martin M, Ybanez A, Narvaez J, Turrion A, Romero-Yuste S, Dominguez-Casas L, Vegas-Revenga N, Martin-Varillas J, Hernandez J, Gonzalez-Vela C, Gonzalez-Gay M, and Blanco R

Published
2018

35. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

Author

Fernández-Díaz C, Loricera J, Castañeda S, López-Mejías R, Ojeda-García C, Olivé A, Rodríguez-Muguruza S, Carreira PE, Pérez-Sandoval T, Retuerto M, Cervantes-Pérez EC, Flores-Robles BJ, Hernández-Cruz B, Urruticoechea A, Maíz-Alonso O, Arboleya L, Bonilla G, Hernández-Rodríguez Í, Palma D, Delgado C, Expósito-Molinero R, Ruibal-Escribano A, Álvarez-Rodríguez B, Blanco-Madrigal J, Bernal J, Vela C, Rodríguez-Gómez M, Fito C, Ortiz-Sanjuán F, Narváez J, Moreno M, López-Corbeto M, Mena-Vázquez N, Aguilera-Cros C, Romero-Yuste S, Ordóñez S, Villa-Blanco I, Gonzélez-Vela MC, Mora-Cuesta V, Palmou-Fontana N, Hernández JL, González-Gay MA, and Blanco R

Subjects
Abatacept, Interstitial lung disease, respiratory system, Rheumatoid arthritis, Biologics, respiratory tract diseases
Abstract

Objective: Interstitial lung disease (ILD) is one of the most serious complications of rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept (ABA) in patients with ILD associated to RA. Methods: National multicenter, non-controlled, open-label registry study of RA patients with ILD treated with ABA. Results: 63 patients (36 women) with RA-associated ILD undergoing ABA therapy were studied. The mean +/- standard deviation age at the time of the study was 63.2 +/- 9.8 years. The median duration of RA and ILD from diagnosis were 6.8 and 1 year, respectively. RA was seropositive in 55 patients (87.3%). In 15 (23.8%) of 63 patients the development of ILD was closely related to the administration of synthetic or biologic disease modifying anti-rheumatic drugs. After a follow-up of 9.4 +/- 3.2 months, two-thirds of patients remained stable whereas one-quarter experienced improvement in the Modified Medical Research Council scale. At that time forced vital capacity remained stable in almost two-thirds of patents and improved in one out of five patients assessed. Also, diffusing capacity of the lung for carbon monoxide remained stable in almost two-thirds and showed improvement in a quarter of the patients assessed. At 12 months, 50% of the 22 patients in whom chest HRCT scan was performed due persistence of respiratory symptoms showed stabilization, 8 (36.4%) improvement and 3 worsening of the HRCT scan pattern. Eleven of 63 patients had to discontinue ABA, mainly due to adverse events. Conclusion: ABA appears to be an effective in RA-associated ILD. (C) 2018 Elsevier Inc. All rights reserved.

Published
2018

36. Principi fondamentali dell'assistenza infermieristica. L'arte e la scienza dell'assistenza infermieristica centrate sui bisogni della persona

Author

Carol, Taylor, Carol, Lillis, Pamela, Lynn, Priscilla, Lemone, Cheever, K. H., Dalley, C. B., Genazzio, E., Goode, V., Hayden, S., Horvath, C., Jasinski, D. M., Rothrock, J. C., Thomas, M. M., Tola, D. H., Burbank, L., O’Brien, J., Smith, C. E., Bacher, M., Batton, K., Lee Berg, M., Bonesteel, J., Botz, D. M., Bridge, D. C., Burnett, P., Castaño, M., Díaz, D. A., Dubose, L. M., Dubose, M. A., Estes, S. L., Goeldner, J. R., Hall, J. M., Harmon, L. G., Heatlie, J., Huber, L. A., Pruskowski Kavanagh, D., Ketcham, P. T., Kincaid, C. A., Lesher, K., Mccarthy, S., Mchugh, M., Montpas, M., Neff, C. K., Ousley, V. A., Parker, K., Pielin-Kircher, J. K., Randol, S. M., Reeves, D., Revis, W. J., Richey, J. A., Robinson, W., Sand-Jecklin, K., Sands, J., Servey, M. S., Shanty, J. A., Sikorski, C., Souter, S., Stellwag, L., Sterling-Guillory, T., Vela, C. G., Stahl Wexler, S., Wilson, S. S., Anduha Wong, K., Amaro, R., Amato, M. G., Bagnasco, A., Bigliardi, M. C., Baldi, L., Borrasso, R., Canella, C., Chiacchio, F., Chiarini, M., Colacci, T., Cozza, J., Crisci, F., De Paola, A., Degan, M., Degola, B. D., Delli Poggi, A., Di Muzio, M., Dionisi, S., Donati, E., Esposito, M. L., Fedi, M., Gazzellone, F., Granato, M., Iacorossi, L., Iannicelli, A. M., La Porta, G., Lombardi, R., Marino, G., Massidda, M. V., Mattei, A., Mungai, D., Ortolani, S., Palazzolo, C., Panzera, N., Papetti, R., Pasqualini, B., Paterniani, A., Penna, A., Oliva Piacentini, E., Pietrini, L., Pinna, M. R., Placenti, F., Savini, S., Scandagli, F., Tibaldi, L., Venditti, G., Zanini, M., and Zenobi, C.

Subjects
nursing
Published
2018

37. High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

Author

Durán‐Vian, C., primary, Arias‐Loste, M.T., additional, Hernández, J.L., additional, Fernández, V., additional, González, M., additional, Iruzubieta, P., additional, Rasines, L., additional, González‐Vela, C., additional, Vaqué, J.P., additional, Blanco, R., additional, Crespo, J., additional, and González‐López, M.A., additional

Published
2019
Full Text
View/download PDF

38. FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS

Author

Martín-Varillas, José Luis, primary, Atienza-Mateo, Belén, additional, Loricera, J., additional, Armesto, Susana, additional, Cuende, Eduardo, additional, Alegre-Sancho, Juanjo J., additional, Moriano, Clara, additional, Calvo-Río, Vanesa, additional, Calderón-Goercke, Monica, additional, Prieto-Peña, D., additional, Bilbao, Lara Sánchez, additional, González-Mazón, Iñigo, additional, González-Vela, C., additional, Luis Hernández, J., additional, Castañeda, Santos, additional, González-Gay, Miguel A., additional, and Blanco, Ricardo, additional

Published
2019
Full Text
View/download PDF

39. AB0612 TEMPORAL ARTERY BIOPSYIN GIANT CELL ARTERITIS. INTERRELATION OF INFLAMMATORY PATTERNS WITH ANALYTICAL DATA AND CLINICAL MANIFESTATIONS

Author

Bilbao, Lara Sánchez, primary, González-Mazón, Iñigo, additional, Prieto-Peña, D., additional, Calderón-Goercke, Monica, additional, Martín-Varillas, José Luis, additional, Atienza-Mateo, Belén, additional, González-Vela, C., additional, González-Gay, Miguel Á., additional, and Blanco, Ricardo, additional

Published
2019
Full Text
View/download PDF

40. Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis

Author

Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS., Evolve Team, Chertow G, Parfrey P, Block G, Drüeke T, Goodman W, Herzog C, London G, Mahaffey K, Moe S, Wheeler D, Hennekens C, Baigent C, Brown W, O'Brien P, Anderson S, Hoel J, Szczech L, Patel U, Wampole J, Pun P, Felker M, Inrig J, Shah S, Hernandez A, Patel C, Brennan M, Albizem M, Capper E, Cauchi L, Cheng S, Dehmel B, Dhami K, Durham C, Francioni M, Gadd S, Goodman B, Guimaraes L, Grey N, Hamlin R, Harris C, Harris E, Heavey S, Heiges T, Heiser D, Jaeger P, James M, James P, Karimi S, Kewalramani R, Kraszewski A, Liang J, Maguire J, McCormick K, McFarlane K, Mix C, Modafferi D, Prathikanti R, Ryan C, Santiago N, Schumacher J, Seder C, Shahinfar S, Soares B, Stolman D, Tisher C, Trotman M, Tseng S, Ulias G, Unger P, Vyshenskaya A, Walsh L, White C, Wilde K, Santos J, Zarazaga C, Marin I, Garrote N, Cusumano A, Penalba N, Del Valle E, Juncos L, Saye J, Lef L, Altobelli V, Petraglia G, Rosa-Diez G, Douthat W, Lobo J, Gallart C, Lafalla A, Diez G, Linares B, Lopez N, Ramirez N, Gonzalez R, Valtuille R, Beresan H, Hermida O, Rudolf G, Marchetta N, Rano M, Ramirez M, Garcia N, Gillies A, Jones B, Pedagogos E, Walker R, Talaulikar G, Bannister K, Suranyi M, Kark A, Roger S, Kerr P, Disney A, Mount P, Fraenkel M, Mathew M, Fassett R, Jose M, Hawley C, Lonergan M, Mackie J, Ferrari P, Menahem S, Sabto J, Hutchison B, Langham R, Pollock C, Holzer H, Oberbauer R, Arias I, Graf H, Mayer G, Lhotta K, Neyer U, Klauser-Braun R, Hoerl W, Horn S, Kovarik J, Kramar R, Eigner M, Dhaene M, Billiouw J, De Meester J, Warling X, Cambier-Dwelschauwers P, Evenepoel P, Daelemans R, Dratwa M, Maes B, Stolear J, Dejagere T, Vanwalleghem J, Bouman K, Jadoul M, Peeters J, Vanholder R, Tielemans C, Donck J, Almeida F, de Oliveira J, Burdmann E, Garcia V, Thome F, Deboni L, Bregman R, Lugon J, Araújo S, Ferreira Filho S, Daher Ede F, Baptista M, Carvalho A, d'Avila D, Moyses Neto M, Yu L, Bastos M, Lacativa P, Jorgetti V, Romão Ede A, da Costa JC, Pecoits Filho R, Gordan P, Salgado N, Araújo M, Coelho S, Oliveira I, Moysés R, Vasconcellos L, Batista P, Gross J, Pedrosa A, Cournoyer S, LeBlanc M, Chow S, Karunakaran S, Wong G, Tobe S, Desmeules S, Zimmerman D, Murphy S, Montambault P, Donnelly S, MacRae J, Culleton B, Soroka S, Rabbat C, Jindal K, Vasilevsky M, Michaud M, Wijeyesinghe E, Zacharias J, Lok C, Muirhead N, Verrelli M, Da Roza G, Sapir D, Olgaard K, Daugaard H, Brandi L, Jensen P, Boulechfar H, Ang K, Simon P, Rieu P, Brunet P, Touchard G, Torres P, Combe C, Durrbach A, Ortiz J, Hannedouche T, Vela C, Lionet A, Ryckelynck P, Zaoui P, Choukroun G, Fessi H, Lang P, Stroumza P, Joly D, Mousson C, Laville M, Dellanna F, Erley C, Braun J, Rambausek M, Riegel W, Klingberg M, Schwertfeger E, Wizemann V, Eckardt K, Reichel H, Passauer J, Hübel E, Frischmuth N, Liebl R, Fiedler R, Schwenger V, Voßkühler A, Kunzendorf U, Renders L, Rattensberger D, Rump L, Ketteler M, Neumayer H, Zantvoort F, Stahl R, Ladanyi E, Braun B, Kulcsar I, Mezei I, Csiky B, Rikker C, Arkossy O, Berta K, Szegedi J, Major L, Ferenczi S, Fekete A, Szabo T, Zakar G, Wagner G, Erdelyine S, Borbas B, Eustace J, Reddan D, Capasso G, Locatelli F, Villa G, Cozzolino M, Brancaccio D, Messa P, Bolasco P, Ricciardi B, Malberti F, Moriero E, Cannella G, Ortalda V, Stefoni S, Frascà G, Cappelli G, Albertazzi A, Zoccali C, Farina M, Elli A, Avella F, Ondei P, Mingardi G, Errico R, Losito A, Di Giulio S, Pertosa G, Schena F, Grandaliano G, Gesualdo L, Auricchio M, Bochicchio-Ricardelli T, Correa-Rotter J, Verástegui F, Peña J, Wong A, Cruz-Valdez J, Zamora M, Solis M, Diaz M, Flores M, Sandoval E, van den Dorpel M, Brink H, Van Kuijk W, Vermeij C, Gregoor P, Hagen E, van der Sande F, Klinger M, Nowicki M, Muszytowski M, Bidas K, Bentkowski W, Wiecek A, Ksiazek A, Marczewski K, Ostrowski M, Switalski M, Sulowicz W, Matuszkiewicz-Rowinska J, Mysliwiec M, Durlik M, Rutkowski B, Macario F, Carvalho B, Frazao J, Machado D, Weigert A, Andrusev A, Khrustalev O, Zemtchenkov A, Gurevich K, Staroselsky K, Khadikova N, Rozhinskaya L, Timokhovskaya G, Strokov A, Balkarova O, Ermolenko V, Kolmakova E, Komandenko M, Timofeev M, Shilo V, Shostka G, Smirnov A, Anashkin V, Volgina G, Domashenko O, Gurevich A, Perlin D, García J, Ribes E, Piera E, Lucas M, Galicia M, Prados M, González M, Romero R, de Francisco ÁM, Montenegro J, Santiago C, García F, de La Ossa J, Arrieta J, Pons J, Martín-Malo A, Amigó J, Cases A, Sterner G, Jensen G, Wikström B, Jacobson S, Lund U, Weiss L, Ståhl A, von Albertini B, Burnier M, Meier P, Martin P, Uehlinger D, Dickenmann M, Yaqoob M, Zehnder D, Kalra P, Padmanabhan N, Roe S, Eadington D, Pritchard N, Hutchison A, Davies S, Wilkie M, Davies M, Pai P, Swift P, Kwan J, Goldsmith D, Tomson C, Stratton J, Dasgupta I, Sarkar S, Moustafa M, Gandhi K, Jamal A, Galindo-Ramos E, Tuazon J, Batlle D, Tucker K, Schiller-Moran B, Assefi A, Martinez C, Samuels L, Goldman J, Cangiano-Rivera J, Darwish R, Lee M, Topf J, Kapatkin K, Baer H, Kopelman R, Acharya M, Tharpe D, Bernardo M, Nader P, Guzman-Rivera J, Pergola P, Sekkarie M, Alas E, Zager P, Liss K, Navarro J, Roppolo M, Denu-Ciocca C, Kshirsagar A, El Khatib M, Kant K, Scott D, Murthyr B, Finkelstein F, Keightley G, McCrary R, Pitone J, Cavalieri T, Tsang A, Pellegrino B, Schmidt R, Ahmad S, Brown C, Friedman E, Mittman N, Fadem S, Shapiro W, Reddy M, Goldberger S, Woredekal Y, Agarwal A, Anger M, Haque M, Chidester P, Kohli R, Rubinstein S, Newman G, Gladish R, Ayodeji O, Soman S, Sprague S, Hunt N, Gehr T, Rizk D, Warnock D, Polack D, Pahl M, Fischer D, Dreyer P, James G, Husserl F, Rogers T, Raff A, Sedor J, Silver M, Smith M, Steinberg S, DelGiorno T, Jones E, Cunha P, Cheng J, Pogue V, Blumenthal S, Brown E, Charytan C, Buerkert J, Cook M, Felsenfeld A, Tareen N, Gupta A, Herman T, Diamond S, Hura C, Laski M, MacLaurin J, Plumb T, Brosnahan G, Kumar J, Henriquez M, Poole C, Osanloo E, Matalon A, Sholer C, Arfeen S, Azer M, Belledonne M, Gross M, Dunnigan E, McConnell K, Becker B, Rigolosi R, Spiegel D, Stegman M, Patak R, Streja D, Ranjit U, Youell T, Wooldridge T, Stafford C, Cottiero R, Weinberg M, Schonefeld M, Shahmir E, Hazzan A, Ashfaq A, Bhandari K, Cleveland W, Culpepper M, Golden J, Lai L, Lien Y, Lorica V, Robertson J, Malireddi K, Morse S, Thakur V, Israelit A, Raguram P, Alfred H, Weise W, Al-Saghir F, El Shahawy M, Rastogi A, Nissenson A, Kopyt N, Lynn R, Lea J, McClellan W, Teredesai P, Ong S, Tolkan S, Sugihara J, Minga T, Mehrotra R, Minasian R, Bhatia D, Specter R, Capelli J, Sidhu P, Dalal S, Dykes P, Khan M, Rahim F, Saklayen M, Thomas A, Michael B, Torres M, Al-Bander H, Murray B, Abukurah A, Gupta B, Nosrati S, Raja R, Zeig S, Braun M, Amatya A, Endsley J, Sharon Z, Dolson G, Dumler F, Ntoso K, Rosansky S, Kumar N, Gura V, Thompson N, Goldfarb D, Halligan R, Middleton J, Widerhorn A, Arbeit L, Arruda J, Crouch T, Friedman L, Khokhar S, Mittleman J, Light P, Taparia B, West C, Cotton J, Dhingra R, Kleinman L, Arif F, Lew S, Nammour T, Sterrett J, Williams M, Ramirez J, Rubin J, McCarthy J, Noble S, Chaffin M, Rekhi A., Chertow, Gm, Block, Ga, Correa-Rotter, R, Drüeke, Tb, Floege, J, Goodman, Wg, Herzog, Ca, Kubo, Y, London, Gm, Mahaffey, Kw, Mix, Tc, Moe, Sm, Trotman, Ml, Wheeler, Dc, Parfrey, Ps., Evolve, Team, Chertow, G, Parfrey, P, Block, G, Drüeke, T, Goodman, W, Herzog, C, London, G, Mahaffey, K, Moe, S, Wheeler, D, Hennekens, C, Baigent, C, Brown, W, O'Brien, P, Anderson, S, Hoel, J, Szczech, L, Patel, U, Wampole, J, Pun, P, Felker, M, Inrig, J, Shah, S, Hernandez, A, Patel, C, Brennan, M, Albizem, M, Capper, E, Cauchi, L, Cheng, S, Dehmel, B, Dhami, K, Durham, C, Francioni, M, Gadd, S, Goodman, B, Guimaraes, L, Grey, N, Hamlin, R, Harris, C, Harris, E, Heavey, S, Heiges, T, Heiser, D, Jaeger, P, James, M, James, P, Karimi, S, Kewalramani, R, Kraszewski, A, Liang, J, Maguire, J, Mccormick, K, Mcfarlane, K, Mix, C, Modafferi, D, Prathikanti, R, Ryan, C, Santiago, N, Schumacher, J, Seder, C, Shahinfar, S, Soares, B, Stolman, D, Tisher, C, Trotman, M, Tseng, S, Ulias, G, Unger, P, Vyshenskaya, A, Walsh, L, White, C, Wilde, K, Santos, J, Zarazaga, C, Marin, I, Garrote, N, Cusumano, A, Penalba, N, Del Valle, E, Juncos, L, Saye, J, Lef, L, Altobelli, V, Petraglia, G, Rosa-Diez, G, Douthat, W, Lobo, J, Gallart, C, Lafalla, A, Diez, G, Linares, B, Lopez, N, Ramirez, N, Gonzalez, R, Valtuille, R, Beresan, H, Hermida, O, Rudolf, G, Marchetta, N, Rano, M, Ramirez, M, Garcia, N, Gillies, A, Jones, B, Pedagogos, E, Walker, R, Talaulikar, G, Bannister, K, Suranyi, M, Kark, A, Roger, S, Kerr, P, Disney, A, Mount, P, Fraenkel, M, Mathew, M, Fassett, R, Jose, M, Hawley, C, Lonergan, M, Mackie, J, Ferrari, P, Menahem, S, Sabto, J, Hutchison, B, Langham, R, Pollock, C, Holzer, H, Oberbauer, R, Arias, I, Graf, H, Mayer, G, Lhotta, K, Neyer, U, Klauser-Braun, R, Hoerl, W, Horn, S, Kovarik, J, Kramar, R, Eigner, M, Dhaene, M, Billiouw, J, De Meester, J, Warling, X, Cambier-Dwelschauwers, P, Evenepoel, P, Daelemans, R, Dratwa, M, Maes, B, Stolear, J, Dejagere, T, Vanwalleghem, J, Bouman, K, Jadoul, M, Peeters, J, Vanholder, R, Tielemans, C, Donck, J, Almeida, F, de Oliveira, J, Burdmann, E, Garcia, V, Thome, F, Deboni, L, Bregman, R, Lugon, J, Araújo, S, Ferreira Filho, S, Daher Ede, F, Baptista, M, Carvalho, A, D'Avila, D, Moyses Neto, M, Yu, L, Bastos, M, Lacativa, P, Jorgetti, V, Romão Ede, A, da Costa, Jc, Pecoits Filho, R, Gordan, P, Salgado, N, Araújo, M, Coelho, S, Oliveira, I, Moysés, R, Vasconcellos, L, Batista, P, Gross, J, Pedrosa, A, Cournoyer, S, Leblanc, M, Chow, S, Karunakaran, S, Wong, G, Tobe, S, Desmeules, S, Zimmerman, D, Murphy, S, Montambault, P, Donnelly, S, Macrae, J, Culleton, B, Soroka, S, Rabbat, C, Jindal, K, Vasilevsky, M, Michaud, M, Wijeyesinghe, E, Zacharias, J, Lok, C, Muirhead, N, Verrelli, M, Da Roza, G, Sapir, D, Olgaard, K, Daugaard, H, Brandi, L, Jensen, P, Boulechfar, H, Ang, K, Simon, P, Rieu, P, Brunet, P, Touchard, G, Torres, P, Combe, C, Durrbach, A, Ortiz, J, Hannedouche, T, Vela, C, Lionet, A, Ryckelynck, P, Zaoui, P, Choukroun, G, Fessi, H, Lang, P, Stroumza, P, Joly, D, Mousson, C, Laville, M, Dellanna, F, Erley, C, Braun, J, Rambausek, M, Riegel, W, Klingberg, M, Schwertfeger, E, Wizemann, V, Eckardt, K, Reichel, H, Passauer, J, Hübel, E, Frischmuth, N, Liebl, R, Fiedler, R, Schwenger, V, Voßkühler, A, Kunzendorf, U, Renders, L, Rattensberger, D, Rump, L, Ketteler, M, Neumayer, H, Zantvoort, F, Stahl, R, Ladanyi, E, Braun, B, Kulcsar, I, Mezei, I, Csiky, B, Rikker, C, Arkossy, O, Berta, K, Szegedi, J, Major, L, Ferenczi, S, Fekete, A, Szabo, T, Zakar, G, Wagner, G, Erdelyine, S, Borbas, B, Eustace, J, Reddan, D, Capasso, G, Locatelli, F, Villa, G, Cozzolino, M, Brancaccio, D, Messa, P, Bolasco, P, Ricciardi, B, Malberti, F, Moriero, E, Cannella, G, Ortalda, V, Stefoni, S, Frascà, G, Cappelli, G, Albertazzi, A, Zoccali, C, Farina, M, Elli, A, Avella, F, Ondei, P, Mingardi, G, Errico, R, Losito, A, Di Giulio, S, Pertosa, G, Schena, F, Grandaliano, G, Gesualdo, L, Auricchio, M, Bochicchio-Ricardelli, T, Correa-Rotter, J, Verástegui, F, Peña, J, Wong, A, Cruz-Valdez, J, Zamora, M, Solis, M, Diaz, M, Flores, M, Sandoval, E, van den Dorpel, M, Brink, H, Van Kuijk, W, Vermeij, C, Gregoor, P, Hagen, E, van der Sande, F, Klinger, M, Nowicki, M, Muszytowski, M, Bidas, K, Bentkowski, W, Wiecek, A, Ksiazek, A, Marczewski, K, Ostrowski, M, Switalski, M, Sulowicz, W, Matuszkiewicz-Rowinska, J, Mysliwiec, M, Durlik, M, Rutkowski, B, Macario, F, Carvalho, B, Frazao, J, Machado, D, Weigert, A, Andrusev, A, Khrustalev, O, Zemtchenkov, A, Gurevich, K, Staroselsky, K, Khadikova, N, Rozhinskaya, L, Timokhovskaya, G, Strokov, A, Balkarova, O, Ermolenko, V, Kolmakova, E, Komandenko, M, Timofeev, M, Shilo, V, Shostka, G, Smirnov, A, Anashkin, V, Volgina, G, Domashenko, O, Gurevich, A, Perlin, D, García, J, Ribes, E, Piera, E, Lucas, M, Galicia, M, Prados, M, González, M, Romero, R, de Francisco, Ám, Montenegro, J, Santiago, C, García, F, de La Ossa, J, Arrieta, J, Pons, J, Martín-Malo, A, Amigó, J, Cases, A, Sterner, G, Jensen, G, Wikström, B, Jacobson, S, Lund, U, Weiss, L, Ståhl, A, von Albertini, B, Burnier, M, Meier, P, Martin, P, Uehlinger, D, Dickenmann, M, Yaqoob, M, Zehnder, D, Kalra, P, Padmanabhan, N, Roe, S, Eadington, D, Pritchard, N, Hutchison, A, Davies, S, Wilkie, M, Davies, M, Pai, P, Swift, P, Kwan, J, Goldsmith, D, Tomson, C, Stratton, J, Dasgupta, I, Sarkar, S, Moustafa, M, Gandhi, K, Jamal, A, Galindo-Ramos, E, Tuazon, J, Batlle, D, Tucker, K, Schiller-Moran, B, Assefi, A, Martinez, C, Samuels, L, Goldman, J, Cangiano-Rivera, J, Darwish, R, Lee, M, Topf, J, Kapatkin, K, Baer, H, Kopelman, R, Acharya, M, Tharpe, D, Bernardo, M, Nader, P, Guzman-Rivera, J, Pergola, P, Sekkarie, M, Alas, E, Zager, P, Liss, K, Navarro, J, Roppolo, M, Denu-Ciocca, C, Kshirsagar, A, El Khatib, M, Kant, K, Scott, D, Murthyr, B, Finkelstein, F, Keightley, G, Mccrary, R, Pitone, J, Cavalieri, T, Tsang, A, Pellegrino, B, Schmidt, R, Ahmad, S, Brown, C, Friedman, E, Mittman, N, Fadem, S, Shapiro, W, Reddy, M, Goldberger, S, Woredekal, Y, Agarwal, A, Anger, M, Haque, M, Chidester, P, Kohli, R, Rubinstein, S, Newman, G, Gladish, R, Ayodeji, O, Soman, S, Sprague, S, Hunt, N, Gehr, T, Rizk, D, Warnock, D, Polack, D, Pahl, M, Fischer, D, Dreyer, P, James, G, Husserl, F, Rogers, T, Raff, A, Sedor, J, Silver, M, Smith, M, Steinberg, S, Delgiorno, T, Jones, E, Cunha, P, Cheng, J, Pogue, V, Blumenthal, S, Brown, E, Charytan, C, Buerkert, J, Cook, M, Felsenfeld, A, Tareen, N, Gupta, A, Herman, T, Diamond, S, Hura, C, Laski, M, Maclaurin, J, Plumb, T, Brosnahan, G, Kumar, J, Henriquez, M, Poole, C, Osanloo, E, Matalon, A, Sholer, C, Arfeen, S, Azer, M, Belledonne, M, Gross, M, Dunnigan, E, Mcconnell, K, Becker, B, Rigolosi, R, Spiegel, D, Stegman, M, Patak, R, Streja, D, Ranjit, U, Youell, T, Wooldridge, T, Stafford, C, Cottiero, R, Weinberg, M, Schonefeld, M, Shahmir, E, Hazzan, A, Ashfaq, A, Bhandari, K, Cleveland, W, Culpepper, M, Golden, J, Lai, L, Lien, Y, Lorica, V, Robertson, J, Malireddi, K, Morse, S, Thakur, V, Israelit, A, Raguram, P, Alfred, H, Weise, W, Al-Saghir, F, El Shahawy, M, Rastogi, A, Nissenson, A, Kopyt, N, Lynn, R, Lea, J, Mcclellan, W, Teredesai, P, Ong, S, Tolkan, S, Sugihara, J, Minga, T, Mehrotra, R, Minasian, R, Bhatia, D, Specter, R, Capelli, J, Sidhu, P, Dalal, S, Dykes, P, Khan, M, Rahim, F, Saklayen, M, Thomas, A, Michael, B, Torres, M, Al-Bander, H, Murray, B, Abukurah, A, Gupta, B, Nosrati, S, Raja, R, Zeig, S, Braun, M, Amatya, A, Endsley, J, Sharon, Z, Dolson, G, Dumler, F, Ntoso, K, Rosansky, S, Kumar, N, Gura, V, Thompson, N, Goldfarb, D, Halligan, R, Middleton, J, Widerhorn, A, Arbeit, L, Arruda, J, Crouch, T, Friedman, L, Khokhar, S, Mittleman, J, Light, P, Taparia, B, West, C, Cotton, J, Dhingra, R, Kleinman, L, Arif, F, Lew, S, Nammour, T, Sterrett, J, Williams, M, Ramirez, J, Rubin, J, Mccarthy, J, Noble, S, Chaffin, M, and Rekhi, A.

Subjects
Adult, Male, Dialysis, Cinacalcet, Cardiovascular Disease, medicine.medical_specialty, Calcimimetic, medicine.medical_treatment, Naphthalenes, Coronary artery disease, Renal Dialysis, Internal medicine, Odds Ratio, medicine, Humans, Intensive care medicine, Aged, Etelcalcetide, Hyperparathyroidism, Hypocalcemia, business.industry, General Medicine, Middle Aged, medicine.disease, Intention to Treat Analysis, Cardiovascular Diseases, Parathyroid Hormone, Cinacalcet Hydrochloride, Kidney Failure, Chronic, Female, Hyperparathyroidism, Secondary, Secondary hyperparathyroidism, business, medicine.drug
Abstract

Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidney disease. It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients.In this clinical trial, we randomly assigned 3883 patients with moderate-to-severe secondary hyperparathyroidism (median level of intact parathyroid hormone, 693 pg per milliliter [10th to 90th percentile, 363 to 1694]) who were undergoing hemodialysis to receive either cinacalcet or placebo. All patients were eligible to receive conventional therapy, including phosphate binders, vitamin D sterols, or both. The patients were followed for up to 64 months. The primary composite end point was the time until death, myocardial infarction, hospitalization for unstable angina, heart failure, or a peripheral vascular event. The primary analysis was performed on the basis of the intention-to-treat principle.The median duration of study-drug exposure was 21.2 months in the cinacalcet group, versus 17.5 months in the placebo group. The primary composite end point was reached in 938 of 1948 patients (48.2%) in the cinacalcet group and 952 of 1935 patients (49.2%) in the placebo group (relative hazard in the cinacalcet group vs. the placebo group, 0.93; 95% confidence interval, 0.85 to 1.02; P=0.11). Hypocalcemia and gastrointestinal adverse events were significantly more frequent in patients receiving cinacalcet.In an unadjusted intention-to-treat analysis, cinacalcet did not significantly reduce the risk of death or major cardiovascular events in patients with moderate-to-severe secondary hyperparathyroidism who were undergoing dialysis. (Funded by Amgen; EVOLVE ClinicalTrials.gov number, NCT00345839.).

Published
2012
Full Text
View/download PDF

41. Spigolature nella tradizione manoscritta delle 'Chiose Selmi'

Author

Ciociola, C., Vela, C., Brambilla, Simona, Simona Brambilla (ORCID:0000-0003-0193-5919), Ciociola, C., Vela, C., Brambilla, Simona, and Simona Brambilla (ORCID:0000-0003-0193-5919)

Abstract

The essay studies the manuscript tradition of the so called "Chiose Selmi" to Dante's Inferno and gives information on the relationships of the manuscripts which contain this text.

Published
2018

43. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial

Author

Moe S. M., Chertow G. M., Parfrey P. S., Kubo Y., Block G. A., Correa-Rotter R., Drueke T. B., Herzog C. A., London G. M., Mahaffey K. W., Wheeler D. C., Stolina M., Dehmel B., Goodman W. G., Floege J., Santos J., Najun Zarazaga C., Marin I., Garrote N., Cusumano A., Penalba N., Del Valle E., Juncos L., Martinez Saye J., Lef L., Altobelli V., Petraglia G., Rosa Diez G., Douthat W., Lobo J., Gallart C., Lafalla A., Diez G., Linares B., Lopez N., Ramirez N., Gonzalez R., Valtuille R., Beresan H., Hermida O., Rudolf G., Marchetta N., Rano M., Ramirez M., Garcia N., Gillies A., Jones B., Pedagogos E., Walker R., Talaulikar G., Bannister K., Suranyi M., Kark A., Roger S., Kerr P., Disney A., Mount P., Fraenkel M., Mathew M., Fassett R., Jose M., Hawley C., Lonergan M., Mackie J., Ferrari P., Menahem S., Sabto J., Hutchison B., Langham R., Pollock C., Holzer H., Oberbauer R., Arias I., Graf H., Mayer G., Lhotta K., Neyer U., Klauser R., Hoerl W., Horn S., Kovarik J., Kramar R., Eigner M., Dhaene M., Billiouw J., De Meester J., Warling X., Cambier-Dwelschauwers P., Evenepoel P., Daelemans R., Dratwa M., Maes B., Stolear J., Dejagere T., Vanwalleghem J., Bouman K., Jadoul M., Peeters J., Vanholder R., Tielemans C., Donck J., Almeida F., Picollo De Oliveira J., Burdmann E., Garcia V., Saldanha Thome F., Deboni L., Bregman R., Lugon J., Araujo S., Ferreira Filho S., De Francesco Daher E., Sperto Baptista M., Carvalho A., D'Avila D., Moyses Neto M., Yu L., Bastos M., Sampaio Lacativa P., Jorgetti V., De Almeida Romao E., Cardeal Da Costa J., Pecoits Filho R., Gordan P., Salgado N., Teixeira Araujo M., Neiva Coelho S., Oliveira I., Moyses R., Vasconcellos L., Batista P., Luiz Gross J., Pedrosa A., Cournoyer S., LeBlanc M., Chow S., Karunakaran S., Wong G., Tobe S., Desmeules S., Zimmerman D., Murphy S., Montambault P., Donnelly S., MacRae J., Culleton B., Soroka S., Rabbat C., Jindal K., Vasilevsky M., Michaud M., Wijeyesinghe E., Zacharias J., Lok C., Muirhead N., Verrelli M., Da Roza G., Sapir D., Olgaard K., Daugaard H., Brandi L., Jensen P., Boulechfar H., Ang K., Simon P., Rieu P., Brunet P., Touchard G., Urena Torres P., Combe C., Durrbach A., Ortiz J., Hannedouche T., Vela C., Lionet A., Ryckelynck P., Zaoui P., Choukroun G., Fessi H., Lang P., Stroumza P., Joly D., Mousson C., Laville M., Dellanna F., Erley C., Braun J., Rambausek M., Riegel W., Klingberg M., Schwertfeger E., Wizemann V., Eckardt K., Reichel H., Passauer J., Hubel E., Frischmuth N., Liebl R., Fiedler R., Schwenger V., Vosskuhler A., Kunzendorf U., Renders L., Rattensberger D., Rump L., Ketteler M., Neumayer H., Zantvoort F., Stahl R., Ladanyi E., Kulcsar I., Mezei I., Csiky B., Rikker C., Arkossy O., Berta K., Szegedi J., Major L., Ferenczi S., Fekete A., Szabo T., Zakar G., Wagner G., Kazup Erdelyine S., Borbas B., Eustace J., Reddan D., Capasso G., Locatelli F., Villa G., Cozzolino M., Brancaccio D., Messa P., Bolasco P., Ricciardi B., Malberti F., Moriero E., Cannella G., Ortalda V., Stefoni S., Frasca G., Cappelli G., Albertazzi A., Zoccali C., Farina M., Elli A., Avella F., Ondei P., Mingardi G., Errico R., Losito A., Di Giulio S., Pertosa G., Schena F., Grandaliano G., Gesualdo L., Auricchio M., Bochicchio-Ricardelli T., Aranda Verastegui F., Pena J., Chew Wong A., Cruz-Valdez J., Torres Zamora M., Solis M., Sebastian Diaz M., Vital Flores M., Alvarez Sandoval E., Van Den Dorpel M., Brink H., Van Kuijk W., Vermeij C., Smak Gregoor P., Hagen E., Van Der Sande F., Klinger M., Nowicki M., Muszytowski M., Bidas K., Bentkowski W., Wiecek A., Ksiazek A., Marczewski K., Ostrowski M., Switalski M., Sulowicz W., Matuszkiewicz-Rowinska J., Mysliwiec M., Durlik M., Rutkowski B., Macario F., Carvalho B., Frazao J., Machado D., Weigert A., Andrusev A., Khrustalev O., Zemtchenkov A., Gurevich K., Staroselsky K., Khadikova N., Rozhinskaya L., Timokhovskaya G., Strokov A., Balkarova O., Ermolenko V., Kolmakova E., Komandenko M., Timofeev M., Shilo V., Shostka G., Smirnov A., Anashkin V., Volgina G., Domashenko O., Gurevich A., Perlin D., Martinez Garcia J., Andres Ribes E., Coll Piera E., Fernandez Lucas M., Galicia M., Prados M., Gonzalez M., Romero R., Martin de Francisco A., Montenegro J., Santiago C., Garcia F., Alcazar De La Ossa J., Arrieta J., Pons J., Martin-Malo A., Soler Amigo J., Cases A., Sterner G., Jensen G., Wikstrom B., Jacobson S., Lund U., Weiss L., Stahl A., Von Albertini B., Burnier M., Meier P., Martin P., Uehlinger D., Dickenmann M., Yaqoob M., Zehnder D., Kalra P., Padmanabhan N., Roe S., Eadington D., Pritchard N., Hutchison A., Davies S., Wilkie M., Davies M., Pai P., Swift P., Kwan J., Goldsmith D., Tomson C., Stratton J., Dasgupta I., Sarkar S., Moustafa M., Gandhi K., Jamal A., Galindo-Ramos E., Tuazon J., Batlle D., Tucker K., Schiller-Moran B., Assefi A., Martinez C., Samuels L., Goldman J., Cangiano-Rivera J., Darwish R., Lee M., Topf J., Kapatkin K., Baer H., Kopelman R., Acharya M., Tharpe D., Bernardo M., Nader P., Guzman-Rivera J., Pergola P., Sekkarie M., Alas E., Zager P., Liss K., Navarro J., Roppolo M., Denu-Ciocca C., Kshirsagar A., El Khatib M., Kant K., Scott D., Murthyr B., Finkelstein F., Keightley G., McCrary R., Pitone J., Cavalieri T., Tsang A., Pellegrino B., Schmidt R., Ahmad S., Brown C., Friedman E., Mittman N., Fadem S., Shapiro W., Reddy M., Goldberger S., Woredekal Y., Agarwal A., Anger M., Haque M., Chidester P., Kohli R., Rubinstein S., Newman G., Gladish R., Ayodeji O., Soman S., Sprague S., Hunt N., Gehr T., Rizk D., Warnock D., Polack D., Pahl M., Fischer D., Dreyer P., James G., Husserl F., Rogers T., Raff A., Sedor J., Silver M., Smith M., Steinberg S., DelGiorno T., Jones E., Cunha P. D., Cheng J., Pogue V., Blumenthal S., Brown E., Charytan C., Buerkert J., Cook M., Felsenfeld A., Tareen N., Gupta A., Herman T., Diamond S., Hura C., Laski M., MacLaurin J., Plumb T., Brosnahan G., Kumar J., Henriquez M., Poole C., Osanloo E., Matalon A., Sholer C., Arfeen S., Azer M., Belledonne M., Gross M., Dunnigan E., McConnell K., Becker B., Skinner F., Rigolosi R., Spiegel D., Stegman M., Patak R., Streja D., Ranjit U., Youell T., Wooldridge T., Stafford C., Cottiero R., Weinberg M., Schonefeld M., Shahmir E., Hazzan A., Ashfaq A., Bhandari K., Cleveland W., Culpepper M., Golden J., Lai L., Lien Y., Lorica V., Robertson J., Malireddi K., Morse S., Thakur V., Israelit A., Raguram P., Alfred H., Weise W., Al-Saghir F., El Shahawy M., Rastogi A., Nissenson A., Kopyt N., Lynn R., Lea J., McClellan W., Teredesai P., Ong S., Tolkan S., Sugihara J., Minga T., Mehrotra R., Minasian R., Bhatia D., Specter R., Capelli J., Sidhu P., Dalal S., Dykes P., Khan M., Rahim F., Saklayen M., Thomas A., Michael B., Torres M., Al-Bander H., Murray B., Abukurah A., Gupta B., Nosrati S., Raja R., Zeig S., Braun M., Amatya A., Endsley J., Sharon Z., Dolson G., Dumler F., Ntoso K., Rosansky S., Kumar N., Gura V., Thompson N., Goldfarb D., Halligan R., Middleton J., Widerhorn A., Arbeit L., Arruda J., Crouch T., Friedman L., Khokhar S., Mittleman J., Light P., Taparia B., West C., Cotton J., Dhingra R., Kleinman L., Arif F., Lew S., Nammour T., Sterrett J., Williams M., Ramirez J., Rubin J., McCarthy J., Noble S., Chaffin M., Rekhi A., Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., Correa-Rotter, R., Drueke, T. B., Herzog, C. A., London, G. M., Mahaffey, K. W., Wheeler, D. C., Stolina, M., Dehmel, B., Goodman, W. G., Floege, J., Santos, J., Najun Zarazaga, C., Marin, I., Garrote, N., Cusumano, A., Penalba, N., Del Valle, E., Juncos, L., Martinez Saye, J., Lef, L., Altobelli, V., Petraglia, G., Rosa Diez, G., Douthat, W., Lobo, J., Gallart, C., Lafalla, A., Diez, G., Linares, B., Lopez, N., Ramirez, N., Gonzalez, R., Valtuille, R., Beresan, H., Hermida, O., Rudolf, G., Marchetta, N., Rano, M., Ramirez, M., Garcia, N., Gillies, A., Jones, B., Pedagogos, E., Walker, R., Talaulikar, G., Bannister, K., Suranyi, M., Kark, A., Roger, S., Kerr, P., Disney, A., Mount, P., Fraenkel, M., Mathew, M., Fassett, R., Jose, M., Hawley, C., Lonergan, M., Mackie, J., Ferrari, P., Menahem, S., Sabto, J., Hutchison, B., Langham, R., Pollock, C., Holzer, H., Oberbauer, R., Arias, I., Graf, H., Mayer, G., Lhotta, K., Neyer, U., Klauser, R., Hoerl, W., Horn, S., Kovarik, J., Kramar, R., Eigner, M., Dhaene, M., Billiouw, J., De Meester, J., Warling, X., Cambier-Dwelschauwers, P., Evenepoel, P., Daelemans, R., Dratwa, M., Maes, B., Stolear, J., Dejagere, T., Vanwalleghem, J., Bouman, K., Jadoul, M., Peeters, J., Vanholder, R., Tielemans, C., Donck, J., Almeida, F., Picollo De Oliveira, J., Burdmann, E., Garcia, V., Saldanha Thome, F., Deboni, L., Bregman, R., Lugon, J., Araujo, S., Ferreira Filho, S., De Francesco Daher, E., Sperto Baptista, M., Carvalho, A., D'Avila, D., Moyses Neto, M., Yu, L., Bastos, M., Sampaio Lacativa, P., Jorgetti, V., De Almeida Romao, E., Cardeal Da Costa, J., Pecoits Filho, R., Gordan, P., Salgado, N., Teixeira Araujo, M., Neiva Coelho, S., Oliveira, I., Moyses, R., Vasconcellos, L., Batista, P., Luiz Gross, J., Pedrosa, A., Cournoyer, S., Leblanc, M., Chow, S., Karunakaran, S., Wong, G., Tobe, S., Desmeules, S., Zimmerman, D., Murphy, S., Montambault, P., Donnelly, S., Macrae, J., Culleton, B., Soroka, S., Rabbat, C., Jindal, K., Vasilevsky, M., Michaud, M., Wijeyesinghe, E., Zacharias, J., Lok, C., Muirhead, N., Verrelli, M., Da Roza, G., Sapir, D., Olgaard, K., Daugaard, H., Brandi, L., Jensen, P., Boulechfar, H., Ang, K., Simon, P., Rieu, P., Brunet, P., Touchard, G., Urena Torres, P., Combe, C., Durrbach, A., Ortiz, J., Hannedouche, T., Vela, C., Lionet, A., Ryckelynck, P., Zaoui, P., Choukroun, G., Fessi, H., Lang, P., Stroumza, P., Joly, D., Mousson, C., Laville, M., Dellanna, F., Erley, C., Braun, J., Rambausek, M., Riegel, W., Klingberg, M., Schwertfeger, E., Wizemann, V., Eckardt, K., Reichel, H., Passauer, J., Hubel, E., Frischmuth, N., Liebl, R., Fiedler, R., Schwenger, V., Vosskuhler, A., Kunzendorf, U., Renders, L., Rattensberger, D., Rump, L., Ketteler, M., Neumayer, H., Zantvoort, F., Stahl, R., Ladanyi, E., Kulcsar, I., Mezei, I., Csiky, B., Rikker, C., Arkossy, O., Berta, K., Szegedi, J., Major, L., Ferenczi, S., Fekete, A., Szabo, T., Zakar, G., Wagner, G., Kazup Erdelyine, S., Borbas, B., Eustace, J., Reddan, D., Capasso, G., Locatelli, F., Villa, G., Cozzolino, M., Brancaccio, D., Messa, P., Bolasco, P., Ricciardi, B., Malberti, F., Moriero, E., Cannella, G., Ortalda, V., Stefoni, S., Frasca, G., Cappelli, G., Albertazzi, A., Zoccali, C., Farina, M., Elli, A., Avella, F., Ondei, P., Mingardi, G., Errico, R., Losito, A., Di Giulio, S., Pertosa, G., Schena, F., Grandaliano, G., Gesualdo, L., Auricchio, M., Bochicchio-Ricardelli, T., Aranda Verastegui, F., Pena, J., Chew Wong, A., Cruz-Valdez, J., Torres Zamora, M., Solis, M., Sebastian Diaz, M., Vital Flores, M., Alvarez Sandoval, E., Van Den Dorpel, M., Brink, H., Van Kuijk, W., Vermeij, C., Smak Gregoor, P., Hagen, E., Van Der Sande, F., Klinger, M., Nowicki, M., Muszytowski, M., Bidas, K., Bentkowski, W., Wiecek, A., Ksiazek, A., Marczewski, K., Ostrowski, M., Switalski, M., Sulowicz, W., Matuszkiewicz-Rowinska, J., Mysliwiec, M., Durlik, M., Rutkowski, B., Macario, F., Carvalho, B., Frazao, J., Machado, D., Weigert, A., Andrusev, A., Khrustalev, O., Zemtchenkov, A., Gurevich, K., Staroselsky, K., Khadikova, N., Rozhinskaya, L., Timokhovskaya, G., Strokov, A., Balkarova, O., Ermolenko, V., Kolmakova, E., Komandenko, M., Timofeev, M., Shilo, V., Shostka, G., Smirnov, A., Anashkin, V., Volgina, G., Domashenko, O., Gurevich, A., Perlin, D., Martinez Garcia, J., Andres Ribes, E., Coll Piera, E., Fernandez Lucas, M., Galicia, M., Prados, M., Gonzalez, M., Romero, R., Martin de Francisco, A., Montenegro, J., Santiago, C., Garcia, F., Alcazar De La Ossa, J., Arrieta, J., Pons, J., Martin-Malo, A., Soler Amigo, J., Cases, A., Sterner, G., Jensen, G., Wikstrom, B., Jacobson, S., Lund, U., Weiss, L., Stahl, A., Von Albertini, B., Burnier, M., Meier, P., Martin, P., Uehlinger, D., Dickenmann, M., Yaqoob, M., Zehnder, D., Kalra, P., Padmanabhan, N., Roe, S., Eadington, D., Pritchard, N., Hutchison, A., Davies, S., Wilkie, M., Davies, M., Pai, P., Swift, P., Kwan, J., Goldsmith, D., Tomson, C., Stratton, J., Dasgupta, I., Sarkar, S., Moustafa, M., Gandhi, K., Jamal, A., Galindo-Ramos, E., Tuazon, J., Batlle, D., Tucker, K., Schiller-Moran, B., Assefi, A., Martinez, C., Samuels, L., Goldman, J., Cangiano-Rivera, J., Darwish, R., Lee, M., Topf, J., Kapatkin, K., Baer, H., Kopelman, R., Acharya, M., Tharpe, D., Bernardo, M., Nader, P., Guzman-Rivera, J., Pergola, P., Sekkarie, M., Alas, E., Zager, P., Liss, K., Navarro, J., Roppolo, M., Denu-Ciocca, C., Kshirsagar, A., El Khatib, M., Kant, K., Scott, D., Murthyr, B., Finkelstein, F., Keightley, G., Mccrary, R., Pitone, J., Cavalieri, T., Tsang, A., Pellegrino, B., Schmidt, R., Ahmad, S., Brown, C., Friedman, E., Mittman, N., Fadem, S., Shapiro, W., Reddy, M., Goldberger, S., Woredekal, Y., Agarwal, A., Anger, M., Haque, M., Chidester, P., Kohli, R., Rubinstein, S., Newman, G., Gladish, R., Ayodeji, O., Soman, S., Sprague, S., Hunt, N., Gehr, T., Rizk, D., Warnock, D., Polack, D., Pahl, M., Fischer, D., Dreyer, P., James, G., Husserl, F., Rogers, T., Raff, A., Sedor, J., Silver, M., Smith, M., Steinberg, S., Delgiorno, T., Jones, E., Cunha, P. D., Cheng, J., Pogue, V., Blumenthal, S., Brown, E., Charytan, C., Buerkert, J., Cook, M., Felsenfeld, A., Tareen, N., Gupta, A., Herman, T., Diamond, S., Hura, C., Laski, M., Maclaurin, J., Plumb, T., Brosnahan, G., Kumar, J., Henriquez, M., Poole, C., Osanloo, E., Matalon, A., Sholer, C., Arfeen, S., Azer, M., Belledonne, M., Gross, M., Dunnigan, E., Mcconnell, K., Becker, B., Skinner, F., Rigolosi, R., Spiegel, D., Stegman, M., Patak, R., Streja, D., Ranjit, U., Youell, T., Wooldridge, T., Stafford, C., Cottiero, R., Weinberg, M., Schonefeld, M., Shahmir, E., Hazzan, A., Ashfaq, A., Bhandari, K., Cleveland, W., Culpepper, M., Golden, J., Lai, L., Lien, Y., Lorica, V., Robertson, J., Malireddi, K., Morse, S., Thakur, V., Israelit, A., Raguram, P., Alfred, H., Weise, W., Al-Saghir, F., El Shahawy, M., Rastogi, A., Nissenson, A., Kopyt, N., Lynn, R., Lea, J., Mcclellan, W., Teredesai, P., Ong, S., Tolkan, S., Sugihara, J., Minga, T., Mehrotra, R., Minasian, R., Bhatia, D., Specter, R., Capelli, J., Sidhu, P., Dalal, S., Dykes, P., Khan, M., Rahim, F., Saklayen, M., Thomas, A., Michael, B., Torres, M., Al-Bander, H., Murray, B., Abukurah, A., Gupta, B., Nosrati, S., Raja, R., Zeig, S., Braun, M., Amatya, A., Endsley, J., Sharon, Z., Dolson, G., Dumler, F., Ntoso, K., Rosansky, S., Kumar, N., Gura, V., Thompson, N., Goldfarb, D., Halligan, R., Middleton, J., Widerhorn, A., Arbeit, L., Arruda, J., Crouch, T., Friedman, L., Khokhar, S., Mittleman, J., Light, P., Taparia, B., West, C., Cotton, J., Dhingra, R., Kleinman, L., Arif, F., Lew, S., Nammour, T., Sterrett, J., Williams, M., Ramirez, J., Rubin, J., Mccarthy, J., Noble, S., Chaffin, M., Rekhi, A., and Clinical sciences

Subjects
Adult, Male, Fibroblast growth factor 23, medicine.medical_specialty, Cinacalcet, Calcimimetic, medicine.medical_treatment, Naphthalenes, Hyperthyroidism, Gastroenterology, ventricular remodeling, Renal Dialysis, Cinacalcet Hydrochloride, Physiology (medical), Internal medicine, medicine, Humans, renal insufficiency, chronic, Aged, Etelcalcetide, calcium, business.industry, Research Support, Non-U.S. Gov't, death, sudden, cardiac, Middle Aged, arrhythmias, cardiac, Cardiovascular Diseases, Female, Fibroblast Growth Factors, Cardiology and Cardiovascular Medicine, medicine.disease, Fibroblast Growth Factor-23, Endocrinology, Randomized Controlled Trial, Secondary hyperparathyroidism, Hemodialysis, business, medicine.drug, Kidney disease
Abstract

Background— Patients with kidney disease have disordered bone and mineral metabolism, including elevated serum concentrations of fibroblast growth factor-23 (FGF23). These elevated concentrations are associated with cardiovascular and all-cause mortality. The objective was to determine the effects of the calcimimetic cinacalcet (versus placebo) on reducing serum FGF23 and whether changes in FGF23 are associated with death and cardiovascular events. Methods and Results— This was a secondary analysis of a randomized clinical trial comparing cinacalcet to placebo in addition to conventional therapy (phosphate binders/vitamin D) in patients receiving hemodialysis with secondary hyperparathyroidism (intact parathyroid hormone ≥300 pg/mL). The primary study end point was time to death or a first nonfatal cardiovascular event (myocardial infarction, hospitalization for angina, heart failure, or a peripheral vascular event). This analysis included 2985 patients (77% of randomized) with serum samples at baseline and 2602 patients (67%) with samples at both baseline and week 20. The results demonstrated that a significantly larger proportion of patients randomized to cinacalcet had ≥30% (68% versus 28%) reductions in FGF23. Among patients randomized to cinacalcet, a ≥30% reduction in FGF23 between baseline and week 20 was associated with a nominally significant reduction in the primary composite end point (relative hazard, 0.82; 95% confidence interval, 0.69–0.98), cardiovascular mortality (relative hazard, 0.66; 95% confidence interval, 0.50–0.87), sudden cardiac death (relative hazard, 0.57; 95% confidence interval, 0.37–0.86), and heart failure (relative hazard, 0.69; 95% confidence interval, 0.48–0.99). Conclusions— Treatment with cinacalcet significantly lowers serum FGF23. Treatment-induced reductions in serum FGF23 are associated with lower rates of cardiovascular death and major cardiovascular events. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00345839.

Published
2015

46. FRI0323 Apremilast therapy in refractory skin lupus lesions

Author

Martín-Varillas, J.L., primary, Loricera, J., additional, Armesto, S., additional, Cuende, E., additional, Calvo-Río, V., additional, González-Vela, C., additional, Atienza-Mateo, B., additional, Hernández, J.L., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

49. AB0669 Maintenance treatment with adalimumab in refractory uveitis due to behÇet’s disease: optimised vs non-optimised group

Author

Martín-Varillas, J.L., primary, Calvo-Río, V., additional, Beltrán, E., additional, Sánchez, J., additional, Mesquida, M., additional, Adán, A., additional, Hernández, M.V., additional, Hernández, M., additional, Valls, E., additional, Martínez, L., additional, Sellas, A., additional, Cordero, M., additional, Díaz, M., additional, Gallego, R., additional, Salom, D., additional, Ortego, N., additional, García, J.L., additional, Callejas, J.L., additional, Herreras, J.M., additional, García, A.M., additional, Maíz, O., additional, Blanco, A., additional, Torre, I., additional, Díaz, D., additional, Pato, E., additional, Aurrecoechea, E., additional, Caracuel, M.A., additional, Gamero, F., additional, Minguez, E., additional, Carrasco, C., additional, Olive, A., additional, Vázquez, J., additional, Ruiz, O., additional, Manero, J., additional, Muñoz, S., additional, Gandía, M., additional, Rubio, E., additional, Toyos, F.J., additional, López, F.J., additional, Nolla, J.M., additional, Revenga, M., additional, González-Vela, C., additional, Loricera, J., additional, Atienza-Mateo, B., additional, Demetrio-Pablo, R., additional, Hernández, J.L., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results